Jean-Baptiste Rieu

38PUBLICATIONS
73CO-AUTHORS
AutoimmunityHaematological tumoursCellular immunologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Jul 08, 2025
Durable Responses With Front-Line Rituximab in Autoimmune Cytopenias Associated With Indolent B-Cell Clones.

Yoann Zadro, Amélie Lusque, Héloïse Rey

|May 15, 2025
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX.

Vincent Jachiet, Olivier Kosmider, Maxime Beydon

|Nov 18, 2024
Mini-consolidations or intermediate-dose cytarabine for the post-remission therapy of AML patients over 60. A retrospective study from the DATAML and SAL registries.

Christian Récher, Pierre-Yves Dumas, Emilie Bérard

|Sep 06, 2023
Vitamin C and D supplementation in acute myeloid leukemia.

Pierre Luc Mouchel, Emilie Bérard, Suzanne Tavitian

|Nov 01, 2022
Prognostic Impact of Unsupervised Early Assessment of Bulk and Leukemic Stem Cell Measurable Residual Disease in Acute Myeloid Leukemia.

Alban Canali, Inès Vergnolle, Sarah Bertoli

|Aug 16, 2022
Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia.

François Vergez, Laetitia Largeaud, Sarah Bertoli

Pageof 7

Frequent Collaborators

14 joint publications

Alban Canali

12 joint publications

Christian Récher

10 joint publications

François Vergez

10 joint publications

Sarah Bertoli